Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Stone foreign body--radiographic and CT appearance.

Maizlin ZV, Vos PM, Lee A, Syed NS, Anaspure RS, Mah JY, Clement JJ.

Emerg Radiol. 2012 Aug;19(4):317-22. doi: 10.1007/s10140-012-1031-6. Epub 2012 Mar 15.

PMID:
22419058
2.

Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

Dugourd D, Yang H, Elliott M, Siu R, Clement JJ, Straus SK, Hancock RE, Rubinchik E.

Antimicrob Agents Chemother. 2011 Aug;55(8):3720-8. doi: 10.1128/AAC.00322-11. Epub 2011 May 16.

3.

Radiologic signs of weapons and munitions: How will noncombatants recognize them?

Maizlin ZV, Kuruvilla M, Clement JJ, Vos PM, Brown JA.

AJR Am J Roentgenol. 2010 Aug;195(2):W96-104. doi: 10.2214/AJR.09.4029.

PMID:
20651180
4.

Displacement of the temporomandibular joint disk: correlation between clinical findings and MRI characteristics.

Maizlin ZV, Nutiu N, Dent PB, Vos PM, Fenton DM, Kirby JM, Vora P, Gillies JH, Clement JJ.

J Can Dent Assoc. 2010;76:a3.

5.

People behind exclusive eponyms of radiologic signs (Part II).

Maizlin ZV, Cooperberg PL, Clement JJ, Vos PM, Coblentz CL.

Can Assoc Radiol J. 2010 Feb;61(1):44-53. doi: 10.1016/j.carj.2009.10.011. Epub 2009 Dec 16. No abstract available.

6.

Novel antimicrobial lipopeptides with long in vivo half-lives.

Pasetka CJ, Erfle DJ, Cameron DR, Clement JJ, Rubinchik E.

Int J Antimicrob Agents. 2010 Feb;35(2):182-5. doi: 10.1016/j.ijantimicag.2009.10.013. Epub 2009 Dec 16.

PMID:
20006467
7.

The role of imagistic simulation in scientific thought experiments.

Clement JJ.

Top Cogn Sci. 2009 Oct;1(4):686-710. doi: 10.1111/j.1756-8765.2009.01031.x. Epub 2009 Jun 11.

8.

People behind exclusive eponyms of radiologic signs (part I).

Maizlin ZV, Cooperberg PL, Clement JJ, Vos PM, Coblentz CL.

Can Assoc Radiol J. 2009 Oct;60(4):201-12. doi: 10.1016/j.carj.2009.06.009. Epub 2009 Jul 31. No abstract available.

9.

Linguistic history of posterior reversible encephalopathy syndrome: mirror of developing knowledge.

Maizlin ZV, Ghandehari H, Maizels L, Shewchuk JR, Kirby JM, Vora P, Clement JJ.

J Neuroimaging. 2011 Jan;21(1):1-4. doi: 10.1111/j.1552-6569.2009.00395.x.

PMID:
19555406
10.

Easy ways to remember the progression of MRI signal intensity changes of intracranial hemorrhage.

Maizlin ZV, Shewchuk JR, Clement JJ.

Can Assoc Radiol J. 2009 Apr;60(2):88-90. doi: 10.1016/j.carj.2009.02.011. Review. No abstract available.

11.

T2 mapping of articular cartilage of glenohumeral joint with routine MRI correlation--initial experience.

Maizlin ZV, Clement JJ, Patola WB, Fenton DM, Gillies JH, Vos PM, Jacobson JA.

HSS J. 2009 Feb;5(1):61-6. doi: 10.1007/s11420-008-9106-3. Epub 2009 Jan 22.

12.

MR arthrography of the wrist: controversies and concepts.

Maizlin ZV, Brown JA, Clement JJ, Grebenyuk J, Fenton DM, Smith DE, Jacobson JA.

Hand (N Y). 2009 Mar;4(1):66-73. doi: 10.1007/s11552-008-9149-4. Epub 2008 Dec 2.

13.

The quinobenzoxazines: relationship between DNA binding and biological activity.

Kwok Y, Sun D, Clement JJ, Hurley LH.

Anticancer Drug Des. 1999 Oct;14(5):443-50.

PMID:
10766299
14.

Corynecandin: a novel antifungal glycolipid from Coryneum modonium.

Gunawardana G, Rasmussen RR, Scherr M, Frost D, Brandt KD, Choi W, Jackson M, Karwowski JP, Sunga G, Malmberg LH, West P, Chen RH, Kadam S, Clement JJ, McAlpine JB.

J Antibiot (Tokyo). 1997 Oct;50(10):884-6. No abstract available.

15.

Production of brominated tiacumicin derivatives

Hochlowski JE, Jackson M, Rasmussen RR, Buko AM, Clement JJ, Whittern DN, McAlpine JB.

J Antibiot (Tokyo). 1997 Mar;50(3):201-5.

16.

Production of brominated tiacumicin derivatives.

Hochlowski JE, Jackson M, Rasmussen RR, Buko AM, Clement JJ, Whittern DN, McAlpine JB.

J Antibiot (Tokyo). 1997 Mar;50(3):201-5.

17.

Discovery of saricandin, a novel papulacandin, from a Fusarium species.

Chen RH, Tennant S, Frost D, O'Beirne MJ, Karwowski JP, Humphrey PE, Malmberg LH, Choi W, Brandt KD, West P, Kadam SK, Clement JJ, McAlpine JB.

J Antibiot (Tokyo). 1996 Jun;49(6):596-8. No abstract available.

18.

Novel triterpene sulfates from Fusarium compactum using a rhinovirus 3C protease inhibitor screen.

Brill GM, Kati WM, Montgomery D, Karwowski JP, Humphrey PE, Jackson M, Clement JJ, Kadam S, Chen RH, McAlpine JB.

J Antibiot (Tokyo). 1996 Jun;49(6):541-6.

19.

Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours.

Alder JD, Jarvis KP, Marsh KC, Klein LL, Clement JJ.

Br J Cancer. 1996 Mar;73(5):560-4.

20.

Dibefurin, a novel fungal metabolite inhibiting calcineurin phosphatase activity.

Brill GM, Premachandran U, Karwowski JP, Henry R, Cwik DK, Traphagen LM, Humphrey PE, Jackson M, Clement JJ, Burres NS, Kadam S, Chen RH, McAlpine JB.

J Antibiot (Tokyo). 1996 Feb;49(2):124-8.

21.

In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.

Flamm RK, Vojtko C, Chu DT, Li Q, Beyer J, Hensey D, Ramer N, Clement JJ, Tanaka SK.

Antimicrob Agents Chemother. 1995 Apr;39(4):964-70.

22.

Biological characterization of a novel antitumor quinolone.

Clement JJ, Burres N, Jarvis K, Chu DT, Swiniarski J, Alder J.

Cancer Res. 1995 Feb 15;55(4):830-5.

23.

Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors.

Permana PA, Snapka RM, Shen LL, Chu DT, Clement JJ, Plattner JJ.

Biochemistry. 1994 Sep 20;33(37):11333-9.

PMID:
7727384
24.

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.

Clement JJ, Tanaka SK, Alder J, Vojtko C, Beyer J, Hensey D, Ramer N, McDaniel D, Chu DT.

Antimicrob Agents Chemother. 1994 May;38(5):1071-8.

25.

Pseudo-symmetrical difluoroketones. Highly potent and specific inhibitors of HIV-1 protease.

Sham HL, Betebenner DA, Wideburg N, Saldivar AC, Kohlbrenner WE, Craig-Kennard A, Vasavanonda S, Kempf DJ, Clement JJ, Erickson JE, et al.

FEBS Lett. 1993 Aug 23;329(1-2):144-6.

26.
28.

Synthesis and activity of C-21 alkylamino derivatives of (9R)-erythromycylamine.

Lartey PA, DeNinno SL, Faghih R, Hardy DJ, Clement JJ, Plattner JJ.

J Antibiot (Tokyo). 1992 Mar;45(3):380-5.

29.

Synthesis and antitumour activities of quinolone antineoplastic agents.

Chu DT, Hallas R, Clement JJ, Alder J, McDonald E, Plattner JJ.

Drugs Exp Clin Res. 1992;18(7):275-82.

PMID:
1338309
30.

Synthesis and antibacterial activities of C-21 functionalized derivatives of (9R)-9-amino-9-deoxoerythromycins A and B.

Lartey PA, DeNinno SL, Faghih R, Hardy DJ, Clement JJ, Plattner JJ, Stephens RL.

J Med Chem. 1991 Dec;34(12):3390-5.

PMID:
1766004
31.

Antitumor activity and biochemical effects of topsentin.

Burres NS, Barber DA, Gunasekera SP, Shen LL, Clement JJ.

Biochem Pharmacol. 1991 Jul 25;42(4):745-51.

PMID:
1867631
32.

In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile.

Swanson RN, Hardy DJ, Shipkowitz NL, Hanson CW, Ramer NC, Fernandes PB, Clement JJ.

Antimicrob Agents Chemother. 1991 Jun;35(6):1108-11.

33.

Cyclobutyl compounds as antiviral agents.

Clement JJ, Kern ER.

Transplant Proc. 1991 Jun;23(3 Suppl 3):159-61. Review. No abstract available.

PMID:
1648823
34.

In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives.

Hardy DJ, Swanson RN, Shipkowitz NL, Freiberg LA, Lartey PA, Clement JJ.

Antimicrob Agents Chemother. 1991 May;35(5):922-8.

35.

Potent HIV-1 protease inhibitors with antiviral activities in vitro.

Sham HL, Betebenner DA, Wideburg NE, Saldivar AC, Kohlbrenner WE, Vasavanonda S, Kempf DJ, Norbeck DW, Zhao C, Clement JJ, et al.

Biochem Biophys Res Commun. 1991 Mar 29;175(3):914-9.

PMID:
2025263
36.

Activity of temafloxacin against respiratory pathogens.

Swanson RN, Hardy DJ, Chu DT, Shipkowitz NL, Clement JJ.

Antimicrob Agents Chemother. 1991 Mar;35(3):423-9.

37.

Synthesis and antitumor activity of structural analogues of the epipodophyllotoxins.

Klein LL, Yeung CM, Chu DT, McDonald EJ, Clement JJ, Plattner JJ.

J Med Chem. 1991 Mar;34(3):984-92.

PMID:
2002477
38.

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.

Hardy DJ, Swanson RN, Rode RA, Marsh K, Shipkowitz NL, Clement JJ.

Antimicrob Agents Chemother. 1990 Jul;34(7):1407-13.

39.
40.
41.

Potential antiradiation drugs containing no nitrogen, and related compounds.

Bowman GT, Clement JJ, Davidson DE Jr, Eswarakrishnan V, Field L, Hoch JM, Musallam HA, Pick RO, Ravichandran R, Srivastava PK.

Chem Biol Interact. 1986 Feb;57(2):161-74. Erratum in: Chem Biol Interact 1986 Jun;58(3):353.

PMID:
3955789
42.

Skin radioprotection by 5-thio-D-glucose.

Schuman VL, Clement JJ, Levitt SH, Song CW.

Radiat Res. 1983 Feb;93(2):326-31.

PMID:
6296912
43.

Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors.

Clement JJ, Johnson RK.

Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):631-4.

PMID:
7107387
44.

Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.

Clement JJ, Johnson RK.

Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):539-42.

PMID:
6286550
45.

Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.

Clement JJ, Gorman MS, Wodinsky I, Catane R, Johnson RK.

Cancer Res. 1980 Nov;40(11):4165-72.

46.

Influence of pyrazofurin on the toxicity and antitumor activity of fluorinated pyrimidines in vivo.

Johnson RK, Howard WS, Faucette LF, Wodinsky I, Clement JJ.

Adv Enzyme Regul. 1980;19:309-33. No abstract available.

PMID:
7337031
47.

Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.

Johnson RK, Wodinsky I, Swiniarski J, Meaney KF, Clement JJ.

Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1605-9. No abstract available.

PMID:
583418
48.

Elimination of hypoxic protection by 5-thio-D-glucose in multicell spheroids.

Song CW, Clement JJ, Levitt SH.

Cancer Res. 1978 Dec;38(12):4499-503.

49.

Tumor reoxygenation and postirradiation vascular changes.

Clement JJ, Tanaka N, Song CW.

Radiology. 1978 Jun;127(3):799-803.

PMID:
663181
50.

Cytotoxic effect of 5-thio-D-glucose on chronically hypoxic cells in multicell spheroids.

Song CW, Sung JH, Clement JJ, Levitt SH.

Br J Cancer Suppl. 1978 Jun;3:136-40.

Supplemental Content

Loading ...
Support Center